Health Condition 1: null- Attention deficit hyperactivity disorder (with and without intellectual disability)
Conditions
Interventions
Intervention1: Methylphenidate: Methylphenidate Immediate release preparation shall comprise the treatment for all the participants. Prescribed in one single morning dose (8 am) or two divided doses (
as well as considering the overall severity of side effects.
Sponsors
Postgraduate Institute of Medical Education anmd Research
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosed with ADHD (as per DSM IV diagnosis confirmed by MINI- KID) and - 2. Drug naïve or 3. Past treatment with any medication for ADHD, but off medications fo
Exclusion criteria
Exclusion criteria: 1. Any other co-morbid psychiatric illness (other than autism, oppositional defiant disorder or conduct disorder, or problem behaviors) 2. Diagnosed with epilepsy or any cardiac disease 3. Presence of tics/ tic disorder 4. Current use of stimulant or any other medication specifically for ADHD symptoms (e.g. clonidine) or an antipsychotic drug 5. History of sensitivity to use of stimulant medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Connersâ?? Parent rating scale (short) 2. Vanderbilt ADHD Diagnostic Parent Rating Scale 3. Aberrant Behaviour Checklist 4. Continuous Performance Task Test 5. Clinical Global Impression scale (Severity and Improvement) 6. Childrens Global Assessment Scale (CGAS) 7. Instrument to measure side effects Timepoint: 1. 2-4 weeks 2. 6-8 weeks 3. 10-12 weeks 4. 16-20 weeks 5. 6-8 months 6. 10-12 months | — |
Countries
India
Contacts
Public ContactRuchita Shah
Outcome results
None listed